BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 34285180)

  • 1. A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination.
    King ER; Towner E
    Am J Case Rep; 2021 Jul; 22():e931478. PubMed ID: 34285180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
    Sato K; Anayama M; Sumi M; Kobayashi H
    Rinsho Ketsueki; 2021; 62(12):1688-1693. PubMed ID: 35022338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.
    Fueyo-Rodriguez O; Valente-Acosta B; Jimenez-Soto R; Neme-Yunes Y; Inclán-Alarcón SI; Trejo-Gonzalez R; García-Salcido MÁ
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34059544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
    Matsumura A; Katsuki K; Akimoto M; Sakuma T; Nakajima Y; Miyazaki T; Fujisawa S; Nakajima H
    Rinsho Ketsueki; 2021; 62(11):1639-1642. PubMed ID: 34866090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of thrombocytopenic purpura following BNT162b2 mRNA COVID-19 vaccination].
    Shibata K; Tanaka H; Otani A; Kubo M; Hasegawa A; Amano I
    Rinsho Ketsueki; 2021; 62(10):1519-1521. PubMed ID: 34732627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
    Ruzicka M; Wurm S; Lindner L; Dreyling M; von Bergwelt-Baildon M; Boeck S; Giessen-Jung C; Milani V; Stemmler JH; Subklewe M; Weigert O; Spiekermann K
    Infection; 2023 Feb; 51(1):231-238. PubMed ID: 36195695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
    J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 Vaccine.
    Ratajczak-Enselme M; Mutoni GC; Desmeules J; Favet L; Ing Lorenzini K
    Acta Haematol; 2023; 146(1):52-57. PubMed ID: 36327915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe thrombocytopenia after COVID-19 mRNA vaccination].
    Hagihara M; Uchida T; Inoue M; Ohara S; Imai Y
    Rinsho Ketsueki; 2021; 62(12):1684-1687. PubMed ID: 35022337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
    Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
    BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune thrombocytopenic purpura and acute liver injury after COVID-19 vaccine.
    Hines A; Shen JG; Olazagasti C; Shams S
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34330722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous Occurrence of Immune-Mediated Thrombocytopenia and Myocarditis After mRNA-1273 COVID-19 Vaccination: A Case Report.
    Bae DH; Kim M; Lee DI; Lee JH; Kim S; Lee SY; Bae JW; Hwang KK; Kim DW; Cho MC
    J Korean Med Sci; 2022 May; 37(21):e169. PubMed ID: 35638196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination.
    Baba Y; Sakai H; Kabasawa N; Harada H
    Intern Med; 2022 Jun; 61(12):1891-1895. PubMed ID: 35400701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.
    Bidari A; Asgarian S; Pour Mohammad A; Naderi D; Anaraki SR; Gholizadeh Mesgarha M; Naderkhani M
    Eur J Haematol; 2023 Apr; 110(4):335-353. PubMed ID: 36562217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of autoimmune hemolytic anemia after BNT162b2 mRNA COVID-19 vaccination].
    Okuno S; Hashimoto K; Shimizu R; Takagi E; Kajiguchi T
    Rinsho Ketsueki; 2021; 62(10):1510-1514. PubMed ID: 34732625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of COVID-19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia.
    Kaicker S; Martinko K; Bussel JB
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30051. PubMed ID: 36317671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
    Welsh KJ; Baumblatt J; Chege W; Goud R; Nair N
    Vaccine; 2021 Jun; 39(25):3329-3332. PubMed ID: 34006408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
    Gordon SF; Clothier HJ; Morgan H; Buttery JP; Phuong LK; Monagle P; Chunilal S; Wood EM; Tran H; Szer J; Crawford NW;
    Vaccine; 2021 Nov; 39(48):7052-7057. PubMed ID: 34756770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune thrombocytopenia associated with Pfizer-BioNTech's BNT162b2 mRNA COVID-19 vaccine.
    Akiyama H; Kakiuchi S; Rikitake J; Matsuba H; Sekinada D; Kozuki Y; Iwata N
    IDCases; 2021; 25():e01245. PubMed ID: 34381692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
    Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
    Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.